ArticleClinical and experimental medicine2025
Development of an explainable machine learning asthma prediction model using serum brominated flame retardants in a national population.
Article in Clinical and experimental medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
We aimed to explore the association of serum brominated flame retardant (BFR) metabolites and mixture profiles with asthma risk among US adults. Data were sourced from the National Health and Nutrition Examination Survey (NHANES), 1999-2023. Four machine learning methods (light gradient boosting machine, eXtreme gradient boosting [XGBoost], random forest, and neural network) annexed with SHapley Additive exPlanations (SHAP) and one traditional logistic regression were used to develop and validate an explainable asthma prediction model. This study included 9,948 US adults. XGBoost outperformed other models with the highest area under the curve (AUC) at 0.814. Sixteen features-family history, BMI, PBDE47, PBDE28, PBDE154, age, race/ethnicity, smoking, second-hand smoking, sex, education, PIR, marriage, drinking, PBDE153, and PBB153-identified by at least two of applied methods were ultimately entered into machine learning models. According to the SHAP-quantified contribution to asthma risk, five key BFRs in predicting asthma were identified: PBDE47, PBDE28, PBDE154, PBDE153, and PBB153. Our findings indicated that XGBoost model proved most effective in predicting adulthood asthma based on serum BFRs. This machine learning-based model holds substantial promise for the early prevention, risk stratification, and clinical management of asthma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.